Advisory Services Network’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Advisory Services Network's RPRX Position: Q2 2026 in Review
Advisory Services Network reduced its Royalty Pharma (RPRX) stake by 26% in Q2 2026, selling an estimated $454K and leaving 25,135 shares worth $1.41M. The position accounts for 0.02% of the portfolio, ranked #848.
Advisory Services Network first reported a position in RPRX in Q3 2020 and has held it in 13 quarters since. The position peaked at $1.77M in Q1 2025. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Advisory Services Network held 25,135 shares of Royalty Pharma worth $1.41M as of Q2 2026.
- Advisory Services Network sold 8,720 Royalty Pharma shares in Q2 2026, an estimated $454K.
- Royalty Pharma made up 0.02% of Advisory Services Network's portfolio in Q2 2026, its #848 holding.
- Advisory Services Network first reported a position in Royalty Pharma in Q3 2020 and has held it in 13 quarters since.
- Advisory Services Network's Royalty Pharma position peaked at $1.77M in Q1 2025.
- 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.